• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA; PERIPHERAL IV CATHETERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA; PERIPHERAL IV CATHETERS Back to Search Results
Catalog Number 383531
Medical Device Problem Code Device Contamination with Chemical or Other Material (2944)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/13/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H.3.A follow up mdr will be submitted if additional information, a device evaluation, or a device history review is completed.
 
Event or Problem Description
It was reported that bd nexiva had condensation within the unit pack.The following information was provided by the initial reporter: the value analyst team at nyu received a report about the bd nexiva kit 24 ga.The report states that ¿bd nexiva kit 24 ga found in clean supply room that was intact but appears to have condensation.This was the only kit affected (the other kits were checked).¿.
 
Additional Manufacturer Narrative
Additional information in b5 investigation results: the reported issue of foreign matter was not confirmed because no sample of the reported batch 3209994 was returned for evaluation.Two samples from unreported batch 3277650 were submitted for evaluation and no instances of foreign matter were observed.Bd could not determine a manufacturing related root cause since no sample was returned that matched the reported product information.We would be very interested in examining product that does not meet your expectations and our quality standards.Should you again experience any problems with our product we would appreciate the opportunity to conduct a thorough analysis of the affected device.Examination of the product involved may provide clarification as to the cause for the reported failure.A review of our risk management documentation was performed and indicates that the potential risk of the reported event was assessed appropriately.Production records were reviewed, and this batch meets our manufacturing specification requirements.
 
Event or Problem Description
Please confirm whether the batch 3277650 is actually the correct batch number for this incident.Response received: according to my report the 3209994 was the affected batch.I do not have record of 3277650 being affected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA
Common Device Name
PERIPHERAL IV CATHETERS
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key19048080
Report Number1710034-2024-00290
Device Sequence Number12601429
Product Code FOZ
UDI-Device Identifier00382903835317
UDI-Public(01)00382903835317
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K183399
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 08/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date07/31/2026
Device Catalogue Number383531
Device Lot Number3209994
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/15/2024
Supplement Date Received by Manufacturer08/15/2024
Initial Report FDA Received Date04/04/2024
Supplement Report FDA Received Date08/15/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/31/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-